|
시장보고서
상품코드
2084821
황열 치료 시장 : 감염 경로별, 치료법별, 용도별, 지역별Yellow Fever Treatment Market, By Transmission Type, By Treatment Type, By Application, By Geography |
||||||
황열 치료 시장은 2026년에 5억 6,420만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 7억 2,850만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 3.7%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 5억 6,420만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 3.70% | 2033년 시장 규모 예측 : | 7억 2,850만 달러 |
황열은 뎅기열과 지카바이러스를 매개하는 네타이시마카에 의해 감염이 확산되는 중증 질환입니다. 이 모기는 보통 열대 우림이나 반습윤 환경, 습윤 환경, 그리고 고인 물 주변에서 번식합니다. 특히 황열 예방접종을 받지 않은 지역에서, 사람과 감염된 모기 간의 접촉이 증가하면 소규모 유행이 발생할 가능성이 있습니다. WHO의 추산에 따르면 이 질병으로 중증 증상을 보인 사람의 50%가 사망하는 것으로 알려져 있습니다. 고령자나 면역 기능이 저하된 사람은 심각한 합병증이 발생할 위험이 있습니다. 황열의 일반적인 증상으로는 두통, 메스꺼움, 발열, 구토 등이 있습니다. 중증의 경우, 황열병은 심장, 신장, 간 등 주요 장기에 영향을 미칩니다.
시장 역학
황열에 관한 연구 및 조사의 증가가 예측 기간 중 전 세계 황열 치료 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 에피센터(Epicentre)가 케냐 의학 연구소, 다카르 파스퇴르 연구소 및 WHO와 공동으로 수행한 연구에서는 케냐의 음바라라, 키리피 및 우간다에서 무작위 이중 맹검 시험이 실시되었습니다. 이 시험은 2017년 11월 6일부터 2018년 2월 21일까지 실시되었습니다. 이 기간 중 연구진은 18세에서 59세 사이의 성인 약 960명을 대상으로, 표준 용량의 5분의 1에 해당하는 황열병 백신을 접종했습니다. 이 연구를 통해 황열병 백신의 5분의 1 양만 접종해도 전량을 접종했을 때와 동등한 효과가 있는 것으로 밝혀졌습니다. 이는 이 치명적인 질병이 유행할 때 더 많은 생명을 구할 수 있음을 의미합니다. 이 연구는 국경없는의사회(MSF)의 연구 부서인 에피센터가 주도했습니다.
본 연구의 주요 특징
- 본 연구는 다양한 부문에서 잠재적인 수익 기회를 규명하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 황열병 치료 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 이 '세계의 황열병 치료제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 황열 치료 시장을 분석하는 데 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 황열 치료 시장 : 감염 경로별, 2021-2033년
제5장 세계의 황열 치료 시장 : 치료 유형별, 2021-2033년
제6장 세계의 황열 치료 시장 : 용도별, 2021-2033년
제7장 세계의 황열 치료 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.07.14Yellow Fever Treatment Market is estimated to be valued at USD 564.2 Mn in 2026 and is expected to reach USD 728.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 564.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.70% | 2033 Value Projection: | USD 728.5 Mn |
Yellow fever is a serious disease spread by Aedes aegypti mosquitoes, which also transmit dengue and Zika viruses. Mosquitoes normally breed in tropical rainforests, semi-humid environments, and humid environments, as well as around bodies of still water. Increased contact between humans and infected mosquitoes, specifically in areas where people haven't been vaccinated for yellow fever, can create small-scale epidemics. The WHO estimates that 50% of people who develop severe symptoms of this condition die. Older adults and those with compromised immune systems are at a risk for serious complications. The common symptoms of yellow fever include headache, nausea, fever, and vomiting. In severe cases, yellow fever affects some key organs such as the heart, kidney, and liver.
Market Dynamics
The increasing research and studies on yellow fever are expected to drive the global yellow fever treatment market growth during the forecast period. For instance, the Epicentre study, in collaboration with the Kenya Medical Research Institute, Institut Pasteur de Dakar, and WHO, carried out a randomized, double-blind trial in Mbarara, Kenya, Kilifi, and Uganda. The trial was carried out between November 6, 2017 and February 21, 2018. During this period, researchers administered one-fifth of a standard dose of yellow fever vaccine to about 960 adults between the ages of 18 and 59 years. In this study, it was found that giving people just one-fifth of a yellow fever vaccine was as effective as giving them a full dose. This means that more lives can be saved during outbreaks of the deadly disease. This study was led by Epicentre, the research arm of Medecins Sans Frontieres / Doctors without Borders (MSF).
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global yellow fever treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos, Institut Pasteur de Dakar, and FSUE Chumakov
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global yellow fever treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global yellow fever treatment market
Market Segmentation
- By Transmission Type (Revenue, USD Mn, 2021-2033)
- Sylvatic Yellow Fever
- Intermediate Yellow Fever
- Urban Yellow Fever
- By Treatment Type (Revenue, USD Mn, 2021-2033)
- Vaccines
- Medications
- Others
- By Application (Revenue, USD Mn, 2021-2033)
- Hospitals
- Clinics
- Community Health Centers
- Others
- By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Sanofi Pasteur SA
- Janssen
- Pfizer Inc.
- BIOCRYST PHARMACEUTICALS, INC.
- Tychan Pte. Ltd.
- Johnson & Johnson Services, Inc.
- Takeda Pharmaceutical Company Limited
- Bayer AG
- GlaxoSmithKline plc
- Bio-Manguinhos
- Institut Pasteur de Dakar
- FSUE Chumakov
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Transmission Type
- Market Snapshot, By Treatment Type
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Yellow Fever Treatment Market, By Transmission Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Sylvatic Yellow Fever
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Intermediate Yellow Fever
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Urban Yellow Fever
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Yellow Fever Treatment Market, By Treatment Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Yellow Fever Treatment Market, By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Community Health Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Yellow Fever Treatment Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Sanofi Pasteur SA
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Janssen
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- BIOCRYST PHARMACEUTICALS, INC.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Tychan Pte. Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Bio-Manguinhos
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Institut Pasteur de Dakar
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- FSUE Chumakov
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Sanofi Pasteur SA
- Analyst Views
9. Section
- References
- Research Methodology
- About Us
